Principal Financial Group
SLXP

Principal Financial Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Principal Financial Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-177,655
Closed -$30.7M – 2281
2015
Q1 		$30.7M Buy
177,655
+8,518
+5% +$1.25M 0.05% 393
2014
Q4 		$19.4M Buy
169,137
+3,799
+2% +$460K 0.03% 548
2014
Q3 		$25.8M Buy
165,338
+8,076
+5% +$1.17M 0.04% 406
2014
Q2 		$19.4M Sell
157,262
-13,511
-8% -$1.49M 0.03% 539
2014
Q1 		$17.7M Buy
170,773
+8,139
+5% +$833K 0.03% 570
2013
Q4 		$14.6M Buy
162,634
+1,293
+0.8% +$103K 0.03% 644
2013
Q3 		$10.8M Sell
161,341
-142,738
-47% -$9.84M 0.02% 767
2013
Q2 		$20.1M Buy
+304,079
New +$17.4M 0.04% 441

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Principal Financial Group's SLXP Position: Q2 2015 in Review

Principal Financial Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 177,655 shares — an estimated $30.7M sold.

Principal Financial Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $30.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Principal Financial Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Principal Financial Group sold 177,655 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $30.7M.
  • Principal Financial Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Principal Financial Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $30.7M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Principal Financial Group's 13F filing for Q2 2015, filed 10 Aug 2015.